Resources search

Working together for better health

DEPARTMENT FOR INTERNATIONAL DEVELOPMENT (DFID)
2007

Expand view

This paper sets out DFID’s strategy to support developing countries in improving the health of their people and reaching the Millennium Development Goals

Access to medicines in under-served markets : what are the implications of changes in intellectual property rights, trade and drug registration policy?

DFID HEALTH SYSTEMS RESOURCE CENTRE (HSRC)
September 2004

Expand view

This overview draws on seven studies commissioned by the UK's Department for International Development. After providing some background, it considers the implications of stronger intellectual property protection for access to medicines; the prospects for supply in emerging and under-served markets; and makes recommendations for increasing access

Emerging challenges and opportunities in drug registration and regulation in developing countries

HILL, Suzanne
JOHNSON, Kent
May 2004

Expand view

This study describes current drug regulation and registration processes in selected countries, in order to understand how they affect the quality and availability of medicines in developing countries. It puts forward policy recommendations as to how systems can more efficiently allow appropriate quality drugs to be marketed and examines the emerging challenges and requirements posed by compulsory licensing, drugs for neglected diseases, anti-retroviral (ARV) and anti-tuberculosis (TB) drugs

GDF drugs, diagnostics and other TB supplies

GLOBAL DRUG FACILITY (GDF)

Expand view

This catalogue lists first-line anti-TB drugs, TB diagnostics equipment and other products currently supplied by the Global Drug Facility (GDF). GDF is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to facilitate global DOTS expansion or maintenance to support the Stop TB Strategy

UNITAID : together to heal

Expand view

UNITAID’s mission is to contribute to scaling up access to treatment for HIV and AIDS, malaria and tuberculosis, primarily for people in low-income countries, by leveraging price reductions for quality diagnostics and medicines and accelerating the pace at which these are made available

E-bulletin

Source e-bulletin on Disability and Inclusion

Subscribe to updates